Skip to main content
. 2017 Aug 11;7(8):e016224. doi: 10.1136/bmjopen-2017-016224

Table 1.

Sample characteristic by sex*

Male Female Total p Value
n (%) 1095 (46.9) 1239 (53.1) 2334
Age (years) 54.0 (14.4) 54.3 (13.8) 54.1 (14.1) 0.648
Baseline weight (kg) 87.2 (15.3) 73.5 (16.1) 79.9 (17.2) <0.001
Follow-up weight (kg) 87.9 (16.0) 74.0 (16.2) 80.5 (17.5) <0.001
Annual weight gain (kg) 0.17 (1.35) 0.12 (1.46) 0.14 (1.41) 0.449
Baseline BMI status
 Normal 21.9 34.5 28.6 <0.001
 Overweight 48.9 34.2 41.1
 Obese 29.2 31.2 30.3
Baseline income ($)
 <20 000 196 (17.9) 332 (26.9) 528
 20 000–60000 529 (48.4) 543 (44.0) 1072
 >60 000 338 (31.0) 308 (24.9) 646
 Not stated 29 (2.7) 52 (4.2) 81 <0.001
Baseline smoking status
 Non-smoker 444 (40.7) 642 (52.0) 1086
 Current or ex-smoker 647 (59.3) 593 (48.0) 1240 <0.001
Baseline physical activity
 Sedentary 252 (25.9) 345 (30.4) 597
 Low exercise level 323 (33.2) 448 (39.5) 771
 Moderate exercise level 291 (29.9) 285 (25.1) 576
 High exercise level 106 (10.9) 56 (4.9) 162 <0.001
Depression (baseline)
 No depressive symptoms 995 (91.3) 1043 (85.4) 2038
 Mild depression 61 (5.6) 122 (10.0) 183
 Moderate to severe depression 34 (3.1) 56 (4.6) 90 <0.001
Depression (follow-up)
 No depressive symptoms 907 (85.6) 958 (79.6) 1865
 Mild depression 101 (9.5) 151 (12.5) 252
 Moderate to severe depression 52 (4.9) 95 (7.9) 147 <0.001
Any antidepressant † 0.4 (1.7) 0.9 (2.5) 0.7 (2.2) <0.001
TCAs † 0.1 (0.6) 0.2 (1.3) 0.1 (1.0) <0.001
SSRIs † 0.2 (1.3) 0.4 (1.6) 0.3 (1.4) 0.019
Other antidepressant † 0.1 (0.8) 0.3 (1.5) 0.2 (1.2) <0.001

*Values are n (%) or mean (SD).

†Annual number of prescriptions.

BMI, body mass index; SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressant.